Skip to main content

Table 1 Summary of chronic dialysis therapy in Japan, 2020

From: Annual dialysis data report 2020, JSDT renal data registry

(a) Number of facilities and dialysis capacity

Number of facilities and dialysis capacity

Number

Changes from previous year (%)

Surveyed facilities

4493

 +6 (+0.1)

Responding facilities

4437

 +26 (+0.6)

Dialysis capacity

  

Number of bedside machines

143,772

 +2252 (+1.6)

Capacity for simultaneous HD treatments

141,752

 +1913 (+1.4)

Maximum patient capacity

472,531

 +7916 (+1.7)

(b) Patient dynamics

Patient category

Number

Changes from previous year (%)

Prevalent patients

347,671

 +3031 (+0.9)

 Prevalence rate (per million of general population)

2754.3

 +22.7

 Patients on nocturnal dialysis

31,468

−559

Incident patients

40,744

−141 (−0.3)

 Started on HD or HDF

38,263

 

 Started on PD

2481

 

Deceased patients

34,414

−228 (−0.7)

(c) Numbers of prevalent dialysis patients by modality

Modality

Outpatients (%)

Inpatients (%)

Total (%)

HD

HD

149,082

(47.0)

22,242

(72.5)

171,324

(49.3)

 

HDF

155,782

(49.0)

8,043

(26.2)

163,825

(47.1)

 

HF

10

(0.0)

4

(0.0)

14

(0.0)

 

HAD

1369

(0.4)

50

(0.2)

1419

(0.4)

 

Home HD

750

(0.2)

1

(0.0)

751

(0.2)

PD

PD only

7916

(2.5)

272

(0.9)

8188

(2.4)

 

PD + HD 1×/week

1839

(0.6)

43

(0.1)

1882

(0.5)

 

PD + HD 2×/week

161

(0.1)

4

(0.0)

165

(0.0)

 

PD + HD 3×/week

30

(0.0)

1

(0.0)

31

(0.0)

 

PD + HD other frequencies

65

(0.0)

7

(0.0)

72

(0.0)

Total

317,004

(100.0)

30,667

(100.0)

347,671

(100.0)

  1. PD + HD patients: patients treated by the combination of PD and HD, HDF, HAD, or HF (excluding those who underwent only peritoneal lavage)
  2. HD, hemodialysis; HDF, hemodiafiltration; HF, hemofiltration; HAD, hemoadsorption dialysis; PD, peritoneal dialysis
  3. HAD refers to hemodialysis therapy combined with hemoadsorption using a tandem-connected beta-2 microglobulin adsorptive column